Capsaicin inhibits plasma membrane NADH oxidase and growth of human and mouse melanoma lines.
Hormone- and growth factor-stimulated NADH oxidase of the mammalian plasma membrane is thought to be involved in the control of normal cell proliferation. The aim of this study was to determine the effect of the naturally occurring quinone analogue capsaicin (8-methyl-N-vanillyl-6-noneamide) on the NADH oxidase activity of plasma membranes and cell growth of human primary melanocytes, the A-375 and SK-MEL-28 human melanoma cell cultures. NADH oxidase activity was inhibited preferentially in the A-375 melanoma cells but not in the primary melanocytes, by capsaicin. Inhibition of growth and the NADH oxidase by capsaicin could be induced in resistant SK-MEL-28 melanoma cells by co-administration of capsaicin with t-butyl hydroperoxide, a mild oxidising agent. Death of the inhibited cells was accompanied by nuclear changes suggestive of apoptosis. With B16 mouse melanoma, capsaicin inhibited both the NADH oxidase activity and growth in culture. Growth of B16 melanoma, transplanted in C57BL/6 mice, was significantly inhibited by capsaicin injected directly into the tumour site when co-administered with t-butyl hydroperoxide. The findings correlate the inhibition of cell surface NADH oxidase activity with inhibition of growth and capsaicin-induced apoptosis, and also suggest that the extent of inhibition may relate to the oxidation state of the plasma membrane.
Morré
D J
DJ
Department of Medicinal Chemistry, Purdue University, West Lafayette, Indiana 47907, USA.
Sun
E
E
Geilen
C
C
Wu
L Y
LY
de Cabo
R
R
Krasagakis
K
K
Orfanos
C E
CE
Morré
D M
DM
D000818:Animals; D002211:Capsaicin / Q000494:pharmacology*; D002455:Cell Division / Q000187:drug effects; D002462:Cell Membrane / Q000201:enzymology; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D008545:Melanoma / Q000188:drug therapy / Q000201:enzymology / Q000473:pathology*; D051379:Mice; D008810:Mice, Inbred C57BL; D009097:Multienzyme Complexes / Q000037:antagonists & inhibitors* / Q000378:metabolism; D009247:NADH, NADPH Oxidoreductases / Q000037:antagonists & inhibitors* / Q000378:metabolism; D010084:Oxidation-Reduction; D012878:Skin Neoplasms / Q000188:drug therapy / Q000201:enzymology / Q000473:pathology*; D014407:Tumor Cells, Cultured / Q000187:drug effects
D009097:Multienzyme Complexes; C023107:NADH oxidase; D009247:NADH, NADPH Oxidoreductases; D002211:Capsaicin